This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethylphenyl group and an aminoethanol moiety, makes it valuable for developing drugs targeting central nervous system disorders, such as antidepressants and antipsychotics. Additionally, it serves as a chiral building block in asymmetric synthesis, enabling the production of enantiomerically pure compounds, which are crucial for enhancing drug efficacy and reducing side effects. Its applications also extend to research and development in medicinal chemistry, where it is used to explore new therapeutic agents and optimize drug candidates.